India's Piramal Pharma sees best day in over 2 weeks
** Shares of Piramal Pharma Ltd PIRM.NS up as much as 4.3%
at 90.50 rupees, their biggest pct gain since Jan. 31
** U.S. Food and Drug Administration (US FDA) has issued an
establishment inspection report for co's manufacturing facility
at Lexington in the U.S, Piramal said on Thursday
** Inspection has now been successfully closed by the US
FDA, it adds
** Stock on track to gain for second consecutive session
** More than 4.5 mln shares traded as of 2:20 p.m IST, 1.4
times their 30-day moving avg
** PIRM down over 24% this year as of last close
(Reporting by Meenakshi Maidas in Bengaluru)
((meenakshi.maidas@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio